朗格汉斯细胞组织细胞增多症
组织细胞增多症
医学
皮肤病科
病理
疾病
作者
Zhengzheng Liu,Yaping Luo,Xinxin Cao
出处
期刊:The Innovation
[Elsevier BV]
日期:2025-05-15
卷期号:6 (9): 100953-100953
被引量:1
标识
DOI:10.1016/j.xinn.2025.100953
摘要
Langerhans cell histiocytosis (LCH) is a rare hematologic disorder that affects patients of all ages. While most of our current understanding of LCH comes from studies of pediatric patients, data on adult cases remain limited. The discovery of the BRAFV600E mutation in approximately 50% of LCH samples established LCH as a neoplastic disease, and subsequent research has identified additional activating mutations in the mitogen-activated protein kinase (MAPK) pathway. Recent advances in our understanding of the disease’s pathogenesis and treatment, combined with its rarity, have highlighted the need for comprehensive guidelines for diagnosing and treating LCH in adults (Figure 1).
科研通智能强力驱动
Strongly Powered by AbleSci AI